You are here

GLM101

Glycomine raises $115m to advance rare disease therapy into Phase IIb

Clinical Trials Arena

Thu, 04/17/25 - 11:05 am

Glycomine funding

Glycomine grabs $115M series C to fund phase 2 journey for rare genetic disorder drug

Fierce Biotech

Wed, 04/16/25 - 11:34 am

clinical trials